Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
136.36%
0%
136.36%
6 Months
52.94%
0%
52.94%
1 Year
-90.8%
0%
-90.8%
2 Years
-96.65%
0%
-96.65%
3 Years
-96.96%
0%
-96.96%
4 Years
-95.38%
0%
-95.38%
5 Years
-95.16%
0%
-95.16%
Yourgene Health Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
46.88%
EBIT Growth (5y)
3.13%
EBIT to Interest (avg)
-4.12
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.10
Sales to Capital Employed (avg)
0.70
Tax Ratio
10.32%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
5.25%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.63
EV to EBIT
-3.32
EV to EBITDA
-18.98
EV to Capital Employed
0.66
EV to Sales
0.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-20.00%
ROE (Latest)
-22.61%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2021
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 7 Foreign Institutions (16.92%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Mar'22
Mar'22
Mar'21
Change(%)
Net Sales
37.60
18.30
105.46%
Operating Profit (PBDIT) excl Other Income
3.10
-3.10
200.00%
Interest
0.70
0.30
133.33%
Exceptional Items
-1.00
-5.50
81.82%
Consolidate Net Profit
-1.90
-12.20
84.43%
Operating Profit Margin (Excl OI)
-40.00%
-349.10%
30.91%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2022 is 105.46% vs 10.24% in Mar 2021
Consolidated Net Profit
YoY Growth in year ended Mar 2022 is 84.43% vs -408.33% in Mar 2021
About Yourgene Health Plc 
Yourgene Health Plc
Medical Specialties
Yourgene Health PLC, formerly Premaitha Health PLC, is engaged in molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for pre-natal screening and other clinical applications in the early detection, monitoring and treatment of disease. The Company's product, the IONA test is a non-invasive in vitro diagnostic product for prenatal screening enabling clinical laboratories to offer a regulated non-invasive prenatal test in-house. The IONA test estimates the risk of a fetus having Down's syndrome or other serious genetic diseases. The risks that fetus may be affected with include Trisomy 21 (Down's syndrome), Trisomy 18 (Edwards' syndrome), Trisomy 13 (Patau's syndrome) and Fetal sex determination optional. The analysis is performed on cell-free placental deoxyribonucleic acid (DNA) from a maternal blood sample, with test results available in three days turnaround time.
Company Coordinates 
Company Details
Enterprise House, Lloyd Street North , MANCHESTER None : M15 6SE
Registrar Details






